IL1A and cancer: Specifically, IL-1-driven inflammatory stimuli in cancer cells enhance lymphangiogenesis and angiogenesis through up-regulation of CXC chemokines, VEGF-A, and VEGF-C, and inducing the transition of macrophages into the lymphangiogenic M2 type.